About 6 million American adults take melatonin on any given day. Most of them bought it at a drugstore with zero medical guidance, swallowed a 5 or 10 mg gummy, and assumed that because it’s “natural,” the risk profile was basically zero.
That assumption deserves a much closer look.
Melatonin is a hormone. Your pineal gland produces it naturally — typically somewhere between 0.1 and 0.5 milligrams per night. The standard supplement doses you’ll find on pharmacy shelves or in your Amazon cart? Often 10 to 20 times higher than that. And the science on what happens when you routinely flood your system with those amounts is, frankly, still catching up to the market.
Here’s what we actually know.
The Melatonin Side Effects That Are Documented (Not Just Anecdotal)
Let me be clear about what “documented” means: these are effects that have appeared consistently in clinical trials and observational studies — not just Reddit threads.
The most commonly reported short-term melatonin side effects include headaches, daytime drowsiness, dizziness, and nausea. These aren’t fringe cases — pooled data from multiple meta-analyses put the headache rate at roughly 8% of participants and dizziness around 6%. Those percentages feel modest until you multiply them across millions of daily users.
Vivid or unusually intense dreams are also well-supported in the literature. Melatonin directly influences REM sleep architecture, and higher doses tend to amplify dream intensity. For some people, this is neutral or even interesting. For those with anxiety or a history of nightmares, it can be meaningfully disruptive.
Drug interactions are where things get more serious. Melatonin can potentiate the effects of anticoagulants like warfarin, which may increase bleeding risk. It also interacts with immunosuppressants, certain seizure medications, and some diabetes drugs by affecting insulin sensitivity. And yet it sits next to the vitamins and protein bars at every checkout counter in America, with no pharmacist consultation required and no warning label for drug interactions.
The FDA regulates melatonin as a dietary supplement under DSHEA — the Dietary Supplement Health and Education Act of 1994. That means manufacturers don’t need to prove it’s safe or effective before selling it. They don’t even need to notify the FDA before bringing a new product to market. The burden of proof runs the other direction: the FDA has to demonstrate harm before it can act. That’s a very different standard than what applies to prescription sleep aids.
The Dosing Problem Nobody Puts on the Label
Here’s the part that took me a while to fully internalize, and I think it’s the most important thing in this whole conversation: the dose that research actually supports for sleep is far lower than what most products contain.
Studies on melatonin for circadian rhythm adjustment — jet lag, shift work, delayed sleep phase disorder — have found real benefits at doses as low as 0.1 to 0.5 mg. That’s the physiological range, close to what your own pineal gland produces. A well-cited 2001 study in the Journal of Clinical Endocrinology & Metabolism found that 0.3 mg performed as well as higher doses for improving sleep onset in older adults, without the next-morning grogginess that higher doses produce.
So why are the most popular products dosed at 5, 10, or even 20 mg?
Some of it is the supplement industry’s longstanding tendency toward “more is better” positioning — higher doses feel like they should work harder. Some may trace back to manufacturing practicality: it’s easier to hit label accuracy at higher concentrations than at tiny fractions of a milligram.
Which is a perfect segue into the labeling problem, because it’s much worse than most people expect.
A 2023 analysis published in JAMA tested 30 commercially available melatonin gummy products and found that 88% of them contained melatonin levels that deviated by more than 10% from what was stated on the label. The actual melatonin content across those products ranged from as low as 74% of the labeled dose to as high as 347% — and some products were dramatically worse. One gummy that claimed 1.5 mg per serving was found to contain nearly 9 mg. That’s not a rounding error; that’s a different product than what you thought you bought.
According to testing data from Qalitex Laboratories, a US-based ISO 17025-accredited supplement testing facility, potency variability is one of the most consistent findings in independent supplement quality assessments. A product can carry the right ingredient and still deliver the wrong dose on any given batch. When that ingredient is a hormone, the margin for error shrinks considerably.
Melatonin and Children: A Concern That Keeps Growing
The American Academy of Pediatrics (AAP) and sleep medicine specialists have been raising concerns about pediatric melatonin use for several years. The data behind those concerns is harder to wave away every time it’s updated.
According to research published in Clinical Toxicology analyzing data from the American Association of Poison Control Centers (AAPCC), melatonin-related calls to poison control involving children under 5 increased by more than 530% between 2012 and 2021. In 2020 alone, there were approximately 52,000 melatonin-related poison control calls nationwide, with children accounting for the overwhelming majority of them.
Most of those cases didn’t result in serious harm — the most common outcomes were vomiting, agitation, or lethargy that resolved on its own. But the trend line is difficult to dismiss. Melatonin increasingly shows up in brightly colored, fruit-flavored gummies with packaging that reads as kid-friendly even when the label says “adult.” Accidental ingestion isn’t surprising. It’s predictable.
The less-discussed concern is intentional use. Pediatric melatonin products are being marketed and purchased without the safety evidence we’d require from a pediatric prescription drug. And melatonin isn’t a neutral compound — it plays a documented role in hormonal regulation and pubertal timing. The honest truth is that we don’t have long-term safety data for chronic melatonin use in children. With a hormonally active compound, that’s not a gap you fill with optimism.
If your child is having genuine sleep difficulties, that conversation belongs with their pediatrician — not with a label claim on a gummy bottle.
When to Reconsider Melatonin Entirely
Melatonin isn’t dangerous for most healthy adults using it occasionally, at low doses, and with some awareness of what else they’re taking. But there are situations where it deserves more scrutiny than most people give it:
If you’re pregnant or trying to conceive. Melatonin has historically been classified under FDA’s Category C — meaning animal studies have indicated potential effects on fetal development, and adequate human data doesn’t exist. Most OB-GYNs advise avoiding it during pregnancy. Because it’s a supplement and not a regulated drug, you’ll rarely see that warning on the bottle.
If you’re on blood thinners, anticonvulsants, or immunosuppressants. These represent the interactions with the strongest clinical evidence. Your prescriber needs to know you’re taking melatonin before you make it a nightly habit.
If daytime grogginess is becoming a pattern. A consistent hangover effect the next morning is a signal — your dose is probably too high, your timing is off, or melatonin simply isn’t the right tool for the sleep problem you’re trying to solve. Remember: it’s a signaling hormone. It tells your body it’s nighttime, it doesn’t knock you out. If you need large doses to feel any effect, that’s information worth acting on.
If you’ve been taking it nightly for months without ever reassessing. The long-term data on chronic daily melatonin use in adults is thin. The concern isn’t that we have strong evidence of harm — it’s that we don’t have strong evidence that chronic use is without consequence. Taking any exogenous hormone every night for years is worth revisiting with a physician, not just continuing on autopilot.
What to Actually Look for Before You Buy
If you do use melatonin, the product quality piece matters more than most labels let on. Third-party verification isn’t a guarantee of perfection, but it does mean someone with a lab and enforceable standards has reviewed what’s in the bottle. Look for seals from NSF International, USP (United States Pharmacopeia), or Informed Sport — these programs test for label accuracy, contaminants, and banned substances.
And genuinely consider starting at 0.5 mg or even 0.3 mg rather than the 5 or 10 mg gummies that dominate the market. Take it 30 to 90 minutes before bed, not right at bedtime. If it works at a lower dose — and the evidence suggests it very likely will — you’ve avoided the grogginess, the label-dose uncertainty, and the physiological overshoot that comes with high-dose supplementation.
Melatonin’s “natural” status has insulated it from the skepticism we’d apply to a pharmaceutical sleep aid with identical effects. The research says the skepticism is warranted, applied carefully, and not at all extreme. Start low, verify what you’re taking, and if sleep problems persist, talk to a doctor — because the conversation is almost certainly bigger than what any supplement can fix.
Written by Nour Abochama, Host & Quality Control Expert, Nourify & Beautify. Learn more about our team
Have questions about product safety? Talk to our experts. Contact us
Related from our network
- Understanding Supplement Label Accuracy: How Independent Testing Works — Qalitex Laboratories explains how ISO 17025-accredited potency testing catches the label discrepancies that most consumers never see
- Raw Material Verification and Why It’s the First Line of Supplement Quality — Ayah Labs breaks down how ingredient-level testing before manufacturing is what separates trustworthy supplements from guesswork
